Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
PaxMedica, Inc. ( (PXMD) ) has shared an update.
On January 31, 2025, PaxMedica, Inc. announced the immediate resignation of Stephen D. Sheldon from his roles as chief financial officer and chief operational officer. He will continue to support the company through a consulting agreement during the transition of his responsibilities to the CEO, clarifying that his departure was not due to any disagreements with the company or its board. Additionally, Zachary Rome resigned from the board on the same date for personal reasons, also confirming no disputes with the company or board.
More about PaxMedica, Inc.
YTD Price Performance: -55.71%
Average Trading Volume: 45,901
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11
For an in-depth examination of PXMD stock, go to TipRanks’ Stock Analysis page.
